Ozpak, Halil BerkanAydin, Cihan2024-10-292024-10-2920231708-53811708-539Xhttps://doi.org/10.1177/17085381231192731https://hdl.handle.net/20.500.11776/14512Aim To evaluate the results of revascularization of stenotic iliac stents using drug-eluting balloons (DEBs). Material and Methods Seventy-four patients with various levels of iliac stent restenosis were enrolled to study. All restenotic stents were treated using paclitaxel-coated balloons. Results Through a follow-up median period of 24 months (4-24 months), there were no in-stent re-restenosis in 55 patients (74.3%) and there was one in class 1 (1.4%), four in class 2 (5.4%), and fourteen in class 3 (18.9%). Conclusion We conclude that; DEBs can be used for restenotic iliac artery stents for some Type C and D lesions, in addition to Types A and B with satisfacting results.en10.1177/17085381231192731info:eu-repo/semantics/closedAccessIliac arterystentrestenosisdrug-eluting balloonendovascular revascularization for iliac artery in-stent restenosisArticleQ4WOS:00103715700000137495213